Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease

Abstract

Adalimumab drug levels were inversely related to disease activity. High levels of anti-adalimumab antibodies were positively associated with disease activity, but this association was mediated mostly by adalimumab drug levels.